tiprankstipranks
Pascal Biosciences Inc (TSE:NEVI)
CNQX:NEVI

Pascal Biosciences Inc (NEVI) Cash flow

3 Followers

Pascal Biosciences Inc Cash Flow

TSE:NEVI's free cash flow for Q3 2023 was C$-166.13K. For the 2023 fiscal year, TSE:NEVI's free cash flow was decreased by C$476.22K and operating cash flow was C$-160.95K. See a summary of the company’s cash flow.
Cash Flow
TTM
Nov 22Nov 21Nov 20Nov 19Nov 18
Operating Cash Flow
C$ -299.32KC$ -147.68KC$ -614.93KC$ -862.83KC$ -3.27MC$ -1.95M
Investing Cash Flow
C$ -924.72KC$ 8.98K--C$ -2.26KC$ -6.53K
Financing Cash Flow
C$ 1.77MC$ 154.84KC$ 624.08KC$ 471.07KC$ 0.00C$ 5.49M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 747.62KC$ 8.37KC$ -7.76KC$ -16.91KC$ 374.85KC$ 3.64M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
C$ 2.00M-C$ 624.50KC$ 341.42KC$ 0.00C$ 5.49M
Issuance Of Debt
C$ -113.55KC$ 174.84KC$ 45.63KC$ 129.65KC$ 0.00-
Repayment Of Debt
C$ -122.51K-----
Free Cash Flow
C$ -288.89KC$ -138.71KC$ -614.93KC$ -862.83KC$ -3.27MC$ -1.96M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Pascal Biosciences Inc Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis